Session 1B. - Hall 4. - Hall 4
|
|
- Kimberly Short
- 5 years ago
- Views:
Transcription
1 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously on PrEP, now pregnant. What to do? (Tshidi Sebitloane) - Teen adherence (Juliet Houghton) - Breast abnormalities in adolescents receiving ART (Jackie Dunlop) Chair: Moherndran Archary 15h30 16h00 Refreshments, exhibition and posters 16h00 17h30 Session 2: Open Session Debate: Undetectable = Untransmittable - Yes (Annemarie Wensing) - No (Graeme Meintjes) Chair: Yunus Moosa and Moeketsi Mathe 17h40 19h00 Session 3: Opening Plenary Opening (Yunus Moosa) Welcome (Moeketsi Mathe) Official conference opening (Desmond Martin) Mechanism of resistance (Douglas Richman) HIV drug resistance: are we about to win the war? (John Mellors) Chair: Annemarie Wensing and Sipho Dlamini 19h00 21h00 Opening Cocktail Function Session 1B Adult cases (Michelle Venter, Kim Roberg, Eric Hefer) - Adherence, Mental health, STIs, Opportunistic Infections, TB, Drug Interactions Panel discussion (Gary Maartens, Yunus Moosa, Ebrahim Variava) Chair: Jeremy Nel Session 1C - Skills building - Nurse cases - Cases primary healthcare, rural doctors (Ndiviwe Mphothulo, Jenny Nash) - Cases nurses (Talitha Crowley, Gloria Mthombeni) - Panel discussion: Integration; Re-starting (Ndiviwe Mphothulo, Talitha Crowley, Gloria Mthombeni, Jenny Nash) Chair: Gloria Maimela Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
2 THURSDAY, 25 OCTOBER h30 08h20 Session 4A Stock outs and medicine availability - Introduction (Flora Bertizzolo) - Not deaf or dead! The seven-year journey of bedaquiline as a third choice for all South Africans with MDR-TB, as told by one fortunate MDR-TB survivor. (Arne von Delft) - Stop Stockouts Project and launch of the 4 th annual medicine availability survey (Tinne Gils) Chair: Anele Yawa 08h30 10h00 Session 5: Plenary Session Welcome (Mylan) - How are we doing with HIV self-screening? (Karin Hatzold) - How are we doing with Universal test and treat? (Francois Venter) - How are we doing with viral suppression? (Sergio Carmona) Chair: Ian Sanne 10h00 10h30 Refreshments, exhibition and posters 10h30 12h00 Session 6A Pharmacovigilance and registers - Pharmacovigilance (Karen Cohen) - Pregnancy register (Mukesh Dheda) - Registers and centralised reporting (Ruth Lancaster) Chair: Gary Maartens Session 4B Ethics and research - The informed consent process (Lucy Allais and Mary Carman) Session 6B - Skills building session Infant testing - Swallowing tablets (Melanie Collins) - Optimising formulations (Carol Ruffell) - The latest on infant testing, and how to access (Gayle Sherman) - Switching in children (Helena Rabie) - Weight and age (Helena Rabie) Chair: James Nuttall Session 6C Ethics and the Law - Whistle-blowing in the health-sector (Karessa Govender) - Mandatory testing (Wayne Ncube) - Ethics on how health budgets are split (Marije Versteeg-Mojanaga) - Q&A Chair: Lucy Allais Southern African HIV Clinicians Society Conference 2018 programme subject to change 3 P a g e
3 12h00 13h30 Lunch, exhibition and posters (Poster track: Paediatric and Adolescents) Satellite Session 7 GlaxoSmithKline / ViiV Healthcare session 13h30 15h00 Session 8A Cancer treatment models - Kaposi Sarcoma (Zainab Mohamed) - Lymphoma (Zainab Mohamed) - Priorities for cervical cancer prevention among HIV-infected women (Masangu Mulongo) - Update on cancer treatment (Adam Nosworthy) Chair: Moosa Patel 15h00 15h30 Refreshments, exhibition and posters 15h30 17h00 Session 9A An update on - NRTIs (Yunus Moosa) - NNRTIs (Michelle Moorhouse) - Protease Inhibitors (Sipho Dlamini) - Integrase inhibitors (Francois Venter) Session 8B Resistance - Viral resistance first-line and secondline (Graeme Meintjes) - At which detectable viral load should we switch? (Lucas Hermans) - Third-line treatment. Feedback on outcome of patients on national thirdline regimen (Michelle Moorhouse) - Transmitted drug resistance: surveillance, implications, future (Cloete van Vuuren) Chair: Theresa Rossouw Session 9B What s coming / What s missing in paediatrics - Integrase inhibitors (James Nuttall) - Protease Inhibitors (Leon Levin) - Drug interactions (Moherndran Archary) Chair: Nosisa Sipambo and Riana van Zyl Women and HIV: Challenges and solutions towards treatment optimization Session 8C Prevention - Non-biomedical approaches (Sue Goldstein) - Condoms (Mags Beksinska) - Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches (Fatima Laher) - Voluntary medical male circumcision (Limakatso Lebina) - Treatment as prevention (Francois Venter) Chair: Fatima Laher Session 9C Modelling and scale-up - What are the numbers telling us (Andrew Boulle) - How the epidemic informs resource planning (Zukiswa Pinini) Southern African HIV Clinicians Society Conference 2018 programme subject to change 4 P a g e
4 - Drug-drug interaction (Gary Maartens) Chair: Karen Cohen 17h10 18h40 Session 10A Skills building session Resistance - Third-line (Leon Levin) - Paediatric third-line (Moherndran Archary) - Stanford database - how to interpret resistance test results (Robert Shafer) Chair: Cloete van Vuuren Session 10B - Skills building session Counselling - How to deliver HIV risk reduction counselling in 2018 (Janan Dietrich) - Integrating HIV prevention with other services (Natasha Davies) - How to tell a teenager they have HIV: A practical approach (Julia Turner) - Uptake and yield of a 24/7 HIV testing service across four Eastern Cape hospital Emergency departments (Dave Stead) Chair: Pierre Brouard 18h50 20h20 Session 11: Debate (Open Session) Hall 4 Implications of scarcer resources for 90:90:90 (Gloria Maimela) - Panel: Elliot Raizes, Annemarie Wensing, Jean Nachega, Francois Venter Chair: Zukiswa Pinini FRIDAY, 26 OCTOBER h30 08h15 Southern African HIV Clinicians Society AGM Cost effectiveness of TLD versus TEE (Gesine Meyer-Rath) Chair: Richard Borain Session 10C National Health Insurance - Keynote: Sasha Stevenson 08h30 10h00 Session 12: Plenary Our current understanding of antibodies (Nono Mkhize) Why do we need cure (John Mellors) How do you measure cure (Monique Nijhuis) Southern African HIV Clinicians Society Conference 2018 programme subject to change 5 P a g e
5 Management of patients with advanced HIV (Graeme Meintjes) 10h00 10h30 Refreshments, exhibition and posters 10h30 12h00 Session 13A Session 13B Opportunistic infections - An approach to intracranial mass lesions in HIV patients (Dave Stead) - Pneumocystis pneumonia (Michelle Wong) - Endemic mycoses in HIV patients (Jade Mogambery) - An approach to chronic diarrhoea (Sipho Dlamini) Chair: Colin Menezes HIV and TB in children and adults - Paediatric TB diagnosis and management (Ashendri Pillay) - TB in children and HIV-TB co-infection (Fiona Kritzinger) - TB in adults and HIV-TB co-infection (Ndiviwe Mphothulo) - TB and HIV co-infection including IRIS (Richard Lessells) Chair: Kogieleum Naidoo 12h00 13h30 Lunch, exhibition and posters (Poster tracks: Antiretroviral Treatment; Primary Health Care and Nursing; Basic Science; Opportunistic Infections and Malignancies; HIV Treatment Failure and Drug Resistance) 13h30 15h00 Session 15: Plenary Botswana Dolutegravir experience (Ava Avalos) Could good point-of-care testing revolutionise issues in the region? (Peter Manyike) Balancing politicians, ministries of health, communities and donors (Paula Munderi) Chairs: (Ebrahim Variava and Muhangwi Mulaudzi) 15h00 15h30 Refreshments, exhibition and posters 15h30 17h00 Session 16A Session 16B Skills building Clinical skills building Should the private sector be treating TB? Yes (Moeketsi Mathe) Session 13C Key populations and mobile populations - Injecting drug users in the region (Andrew Scheibe) - Sex workers including satellite clinics; peer support (Naomi Hill) - Engaging in care (Naomi Hill) - Testing in taxi ranks (Thandeka Khoza) Chair: Kholi Buthelezi Satellite Session 14 GILEAD session Session 16C Update on PMTCT Southern African HIV Clinicians Society Conference 2018 programme subject to change 6 P a g e
6 (Yunus Moosa, Richard Lessells, Farai Russell Sigauke) No (Ebrahim Variava) Chair: Kogieleum Naidoo - Where are we with PMTCT, including epidemiology (Landon Myer) - Transmission of HIV in breastfeeding (Ameena Goga) - Pregnant women on ART programmatic issues (Coceka Mnyani) - Contraception, clinical issues, MPTs and new technologies (Helen Rees) Chair: Tshidi Sebitloane 17h10 18h40 Session 17 Hall 4 Dolutegravir in pregnancy - Overview (Landon Myer) - DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy (Catherine Orrell) - Dolutegravir rollout (Steven Smith) Chair: Sipho Dlamini and Francois Venter 19h00 22h30 Celebratory Dinner (RSVP only additional fee applies) Entertainment provided The Veldt SATURDAY, 27 OCTOBER h30 08h15 Session 18 Auditorium Meet the Professor / Clinician How did I start my academic / research career? (Dave Spencer; Francois Venter; Michelle Moorhouse; Yunus Moosa; Gary Maartens; Chris Jack) 08h30 10h00 Session 19: Plenary Vaccinations - Overview (Benjamin Kagina) - Influenza vaccines (Marta Nunes) Southern African HIV Clinicians Society Conference 2018 programme subject to change 7 P a g e
7 - HIV vaccines (Nivashnee Naicker) - SAHCS vaccination guidelines (Sipho Dlamini) Chair: Rudzani Muloiwa 10h00 10h30 Refreshments, exhibition and posters 10h30 12h00 Session 20A Session 20B Noncommunicable diseases - Inflammation (Dave Spencer) - Hypertension (Ebrahim Variava) - Obesity (Denasha Reddy) - Mental health (John Joska) - Injection drug use, HIV and hepatitis (Moeketsi Mathe) Chair: Marlin McKay Ethics and technology - Digital database and the PoPI act (Siraaj Adams) - Ethico-legal framework for biobank research in SA (Safia Mahomed) - EMGuidance (Mohammed Dalwai) Chair: Funeka Bango 12h00 13h30 Lunch, exhibition and posters (Poster tracks: Operations Research; Prevention; TB; Women s Health; Key Populations; Non-Communicable Diseases; Clinical Skills Building) Session 20C Sexually transmitted infections - Strategies to achieve STI control in South Africa (Remco Peters) - Hepatitis C (Andrew Scheibe) - In context of PrEP (Danielle Travill) - Management of STIs in HIV+ population (Ranmini Kuluratne) Chair: Helen Rees Satellite Session 21 Johnson & Johnson session - Optimising treatment for life-long management of HIV 13h30 15h00 Session 22A - Advanced HIV Management - Care of aging patients (Marlin McKay) - Cryptococcal meningitis (Charlotte Sriruttan) - Palliative care (Dave Spencer) Chair: Dave Spencer Session 22B Treatment optimisation - Overview of all medications currently available (Landon Myer) - Can we use dolutegravir second-line? (Graeme Meintjes) - New ARVs and surveillance (Michelle Moorhouse) - Low-dose darunavir (Francois Venter) Chair: Polly Clayden Session 22C Best abstracts session - Constructing TB cascades to inform TB programme improvement (Kate Rees) - HIV drug resistance profiles in patients failing integrase strand transfer inhibitors in the South African public sector (Kim Steegen) Southern African HIV Clinicians Society Conference 2018 programme subject to change 8 P a g e
8 15h10 16h40 Session 23A Skills building Guidelines - Vaccination guidelines (Sipho Dlamini) - Safer conception guidelines (Natasha Davies) Session 23B Adherence - What is new in adherence (Catherine Orrell) - Virological monitoring how it relates to adherence (Richard Lessells) - Continued Use of PrEP among Sex Workers in Six Sites in South Africa (Cara O Connor) - Linking paediatric, adolescent and adult patients to care through the implementation of clinic navigators in high volume facilities (Chantal Smith) - Perceptions of HIV-Self Screening (Nthabiseng Koloane) - Viral load suppression among pregnant women presenting on ART in antenatal care; Chiredzi District Zimbabwe (Talent Maphosa) - Evaluation of the new Option B+ PMTCT program for HIV at hospital facilities: case study at the Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa (Melanie Bisnauth) - Triple-NRTI regimens while on TB treatment in a resource constrained setting a paediatric cohort analysis (Jennifer Minnaar) - Youth Care Clubs: Optimising clinic time, fostering peer support, improving adherence (Moira Beery) Session 23C - Quality Improvement The Aurum Institute (Lauren de Kock, Winnet Chiningwenya) Southern African HIV Clinicians Society Conference 2018 programme subject to change 9 P a g e
9 - Adult antiretroviral therapy guidelines (Michelle Moorhouse) - Palliative care guidelines (Dave Spencer) - Self screening (Naleni Rhagnath) - Adherence and the related science (Nithendra Manickchund) Chair: Maria Sibanyoni 16h50 18h15 Session 24: Closing Plenary Big challenges in TB drug resistance (Richard Lessells) Big challenges in introducing and scaling up new prevention technologies (Helen Rees) Big challenges in public health with essential medicine availability (Anele Yawa) Chair: Gary Maartens 18h15 18h20 Conference closing Moeketsi Mathe Southern African HIV Clinicians Society Conference 2018 programme subject to change 10 P a g e
15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
More informationSession 1B. - Hall 4. 15h30 16h00 Refreshments, exhibition and posters - Hall 5 16h00 17h30 Session 2: Open Session. - Hall 4
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
More informationSouthern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
More informationSession 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
More informationversus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
WEDNESDAY, 24 SEPTEMBER 2014 SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme 12h00-19h00 REGISTRATION 10h00-14h00 PRE-CONFERENCE WORKSHOP Metropolitan Health sponsored
More informationUpdates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013
Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will
More informationSA HIV Clinicians Society Conference Excelling in Clinical Care : Programme
SA HIV Clinicians Society Conference 2014 - Excelling in Clinical Care : Programme WEDNESDAY, 24 SEPTEMBER 2014 08h00-19h00 10h00-13h55 12h30 13h55 REGISTRATION PRE-CONFERENCE WORKSHOP Metropolitan Health
More informationTasP and PrEP- Wishful thinking in the developing world?
TasP and PrEP- Wishful thinking in the developing world? Professor Helen Rees Executive Director, WRHI, Wits Reproductive Health and HIV Institute & Ad Hominem Professor, Department of Ob/Gyn, University
More informationSouth Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018
South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationGoal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84
Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care
More informationPLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE
CHAPTER 2 PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE 2.1 INTRODUCTION Achieving quality integrated HIV services at your health centre is dependant on good planning and management. This chapter
More information2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall
2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University
More informationHow are we doing with Universal Test and Treat?
How are we doing with Universal Test and Treat? Francois Venter October 2018 Thanks DoH, WHO, PEPFAR, CHAI, UCT, Joep Lange Institute, Celicia Serenata, Steve Smith, David Allen Optimising ART Consortia
More informationImpact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines
Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,
More informationWHO WHO AIDS 2018 JOIN US AT
WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases
More informationEfavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST. Graeme Meintjes University of Cape Town
Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST Graeme Meintjes University of Cape Town Benefits of dolutegravir Superior efficacy in SINGLE trial Side effect profile
More informationITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group.
ITREMA is a collaborative project between several universities in The Netherlands and South Africa and Ndlovu Care Group. Objective: To do research into the best way to use viral load testing to ensure
More informationProgramme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016
EVIDENCE TOACTION This session will highlight the essential role that collaborative research plays in improving public sector policies and services for HIV treatment and prevention. Across southern Africa
More informationPrioritized research questions for adolescent HIV testing, treatment and service delivery
Prioritized research questions for adolescent HIV testing, treatment and service delivery The World Health Organization (WHO) and the Collaborative Initiative for Paediatric HIV Education and Research
More informationImmunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN
Immunisation in people living with HIV Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Calculating immunisation s return on investment In Gavi-supported countries, 2011 2020 48x (full income
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationTRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES
POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment
More informationCan we make first line ART better?
Can we make first line ART better? Dr David Stead Treatment Optimization HIV Clinicians Society Workshop 25 November 2017 With thanks to Francois Venter and the people who gave him slides Characteristics
More informationThe elimination equation: understanding the path to an AIDS-free generation
The elimination equation: understanding the path to an AIDS-free generation James McIntyre Anova Health Institute & School of Public Health & Family Medicine, University of Cape Town Elimination of perinatal
More informationCan we make first line ART better?
Can we make first line ART better? Dr Angela Hartwig 8 th SA AIDS Conference, Durban Skills Building Session 15 June 2017 With thanks to Francois Venter and the people who gave him slides Characteristics
More informationFuture trends of drug resistance and prospects of antiviral therapy. Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018
Future trends of drug resistance and prospects of antiviral therapy Doug Richman International Drug Resistance Workshop Johannesburg 24 October 2018 The principles of HIV drug resistance are well established
More informationPage 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory
More informationInvesting for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS
Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation
More informationINTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION
INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES WHO guidelines [EXECUTIVE SUMMARY] NDoH PrEP policy [FULL] NDoH PrEP guidelines [FULL] FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION
More informationFirst line ART Rilpirivine A New NNRTI. Chris Jack Physician, Durdoc Centre ethekwini
First line ART Rilpirivine A New NNRTI Chris Jack Physician, Durdoc Centre ethekwini Overview: Rilpirivine an option for ARV Naïve patients History Current guidelines Efficacy and Safety Tolerability /
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationIs dolutegravir a magic bullet for HIV/TB programmes?
Francois Venter Is dolutegravir a magic bullet for HIV/TB programmes? March 2018 Thanks Michelle Moorhouse, Graeme Meintjes, Gary Maartens, Celicia Serenata, Andy Hill, Polly Clayden, Gloria Maimela, Tom
More informationHIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016
HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &
More informationTB and HIV co-infection including IRIS
TB and HIV co-infection including IRIS Richard Lessells SAHCS Conference 2018 Clinical scenario 1 36-year-old male Presents with cough, fever & weight loss HIV test positive (new diagnosis) Sputum Xpert
More informationCatherine Martin. Abstract #157. SA AIDS Conference. June 2017
Catherine Martin SA AIDS Conference Integrated sexual and reproductive health services as an entry point to HIV testing, prevention and care for adolescent girls and young women in Johannesburg, South
More informationVirologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study.
Virologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study. K. Reichmuth 1, J. Nuttall, H. Rabie, B. Eley, H. Moultrie,
More informationTHE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA
THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA 2012-2016 South African Society of Physiotherapy P.O. Box 752378 Gardenview
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationART TREATMENT PROGRAMME 2004
Presentation title ART TREATMENT PROGRAMME 2004 Cabinet decision in 29 th November 2003 Initial sites were hospital based, required central review National Costing Model of HIV/AIDS Treatment 2010 Cost
More informationEbrahim Bera Department of Obstetrics & Gynaecology Rahima Moosa Mother-and-Child Hospital Wits University 28 November 2012
Ebrahim Bera Department of Obstetrics & Gynaecology Rahima Moosa Mother-and-Child Hospital Wits University 28 November 2012 Euphoria around survival from HIV 1.9 million people in SA now on ART New HIV
More informationHIV and AIDS Estimates
and AIDS Estimates Adults and children living with Adults aged 15 and over living with Women aged 15 and over living with Men aged 15 and over living with 200 000 [180 000-210 000] 190 000 [170 000-200
More informationUganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.50 Demographic and socioeconomic data Uganda HIV Country Pro le: 2017 42.9 million Total population (2017) 1 820 US$ GNI per capita, PPP (2017) 343 Maternal mortality per 100 000 live births
More informationWHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team
WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic
More informationCote D'Ivoire. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.50 Demographic and socioeconomic data Cote D'Ivoire HIV Country Pro le: 2017 24.3 million Total population (2017) 3 820 US$ GNI per capita, PPP (2017) 645 Maternal mortality per 100 000
More informationPEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried
PEPFAR Priorities & HIV Drug Resistance: Where are we heading and what has us worried Elliot Raizes, MD Division of Global HIV & TB CDC Center for Global Health May 3, 2016 Center for Global Health Division
More informationSouth African goals and national policy
Connecting the dots for EMTCT A Decade of PMTCT South Africa has been one of the counties in sub-saharan Africa to be hard hit by the HIV virus. Despite this, the country did not implement its PMTCT programme
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationDifferentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization
Differentiated Care Improving Engagement and Retention in HIV Care Meg Doherty, MD PhD MPH World Health Organization Why differentiated care and how can it facilitate epidemic control Effects on linkage,
More informationHIV Epidemic in India
HIV Epidemic in India Dr.R.R.Gangakhedkar Head, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research New Delhi Waves in Spread of HIV Epidemic Core Group Bridge Populationmostly
More informationBreast Abnormalities in Adolescents receiving Antiretroviral Therapy. Dr Jackie Dunlop 24 October 2018
Breast Abnormalities in Adolescents receiving Antiretroviral Therapy Dr Jackie Dunlop 24 October 2018 Introduction Gynaecomastia related to ART in adult males is well documented Few studies have described
More informationSA HIV Clinicians Society Adult ART guidelines
SA HIV Clinicians Society Adult ART guidelines In draft format Graeme Meintjes (on behalf of the guidelines committee) Selected topics When to start ART First-line Second-line Third-line Patients with
More informationTreat All : From Policy to Action - What will it take?
Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions
More informationSHOULD A TRIAL EVALUATING THE USE OF LOW DOSE STAVUDINE BE CONDUCTED?
SHOULD A TRIAL EVALUATING THE USE OF LOW DOSE STAVUDINE BE CONDUCTED? ETHICAL, CLINICAL AND COMMUNITY CONSIDERATIONS Eric Goemaere, MD, DTMH, PHD Senior HIV/TB program adviser MSF South Africa We loved
More informationPRECONCEPTION COUNSELING
PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal
More informationCOMMUNITY SYSTEMS TOOLBOX COMMUNITY SYSTEMS STRENGTHENING. Increasing access to quality health and social services. Building strong communities.
#4 COMMUNITY SYSTEMS TOOLBOX COMMUNITY SYSTEMS STRENGTHENING Increasing access to quality health and social services. Building strong communities. Coordinated, capacitated and resilient communities play
More informationImpact of ART resistance in sub Saharan Africa
Impact of ART resistance in sub Saharan Africa Elliot Raizes, MD Division of Global HIV/TB US Centers for Disease Control and Prevention ITREMA Resistance Training Workshop 24 October, 2018 Center for
More informationJOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN
JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationBotswana. HIV Country Profile: Health expenditure, total (% of GDP) (2016) Total fertility rate (births per woman) ( )
WHO/CDS/HIV/18.5 Demographic and socioeconomic data Botswana HIV Country Profile: 217 2.3 million Total population (217) 16 99 US$ GNI per capita, PPP (217) World Bank 129 Maternal mortality per 1 live
More informationThe CQUIN Learning Network. Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda
The CQUIN Learning Network Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda Teddy N. Chimulwa STD/AIDS Control Program, Ministry of
More informationHIV and AIDS Estimates
and AIDS Estimates Adults and children living with Adults aged 15 and over living with Women aged 15 and over living with Men aged 15 and over living with 1 300 000 [1 200 000-1 500 000] 1 200 000 [1 100
More informationADOLESCENTS AND HIV:
Elizabeth Glaser Pediatric AIDS Foundation Until no child has AIDS. Photo by Eric Bond/EGPAF, 2015 ADOLESCENTS AND HIV: PRIORITIZATION FOR ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION PROGRAMS, ADVOCACY
More informationBotswana Advocacy paper on Resource Mobilisation for HIV and AIDS
Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.
More informationStarting with the end in mind: Experience of transitioning to sustainable services (KZN)
Starting with the end in mind: Experience of transitioning to sustainable services (KZN) Hilton Humphries Adolescent Programme Director MA (Research Psychology), PhD candidate Position: Behavioural Scientist
More informationINTERNAL QUESTIONS AND ANSWERS DRAFT
WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving
More informationOverview of Safer Conception Services at Wits RHI
SA AIDS Satellite Session 13 June 2017 Presented by Diantha Pillay on behalf of Dr. Natasha Davies, Sheree Swartz, Nicolette Naidoo & Saiqa Mullick Overview of Safer Conception Services at Wits RHI Safer
More informationEACS HIV Summer School PRELIMINARY PROGRAMME
EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationManagement of HIV Infected Children and Adolescents: Public Sector Approach in Kenya
Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya KPA 2018 24-04-2018 Dr. Margaret Wainaina- Wafula Outline Introduction Evaluation of a child living with HIV. Standard
More information7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME
THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationSPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV
SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV PREVENTION COALITION MEETING, 10 OCTOBER2017 I have said many times, and wish to repeat, that
More informationDiagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar
Diagnosing HIV/AIDS Marissa Humphrey MSIV New York Medical College GE/NMF Scholar Introduction The World Health Organization estimates that 7 percent of all AIDS cases have occurred in Africa and the highest
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationEvolving HIV Treatment Paradigms What we need to know
Evolving HIV Treatment Paradigms What we need to know Benjamin Young International Association of Providers of AIDS Care Washington, DC, USA Evolving HIV Treatment Paradigms When/who to treat Better medicines
More informationAchieving the 3 rd 90 in PEPFAR-supported countries:
Center for Global Health Achieving the 3 rd 90 in PEPFAR-supported countries: What will it take? Is it enough? Elliot Raizes, MD Division of Global HIV and TB Centers for Disease Control and Prevention
More informationOUR YOUTH - OUR FUTURE : STREN
OUR YOUTH - OUR FUTURE : STREN GTHENING HEALTH SYSTEMS FOR ADOLESCENTS AND YOUTH WHY WE ARE NEEDED The priority of the National Department of Health (NDoH) is to improve the health status of the entire
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationClinical Cases: Integrase Inhibitor use in Africa. Dr Julia Turner Medical Advisor Right to Care NGO
Clinical Cases: Integrase Inhibitor use in frica Dr Julia Turner Medical dvisor Right to Care NGO Disclosure Receipt of grants/ research supports Right to Care NGO is funded by USID PEPFR, ealth Systems
More informationART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
More informationLOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions
1 Outcome 7 countries have addressed barriers to efficient and effective linkages between HIV and SRHR policies and services as part of strengthening health systems to increase access to and use of a broad
More informationLiving Positively with HIV
Living Positively with HIV Pregnancy and Planning a Family How do I avoid pregnancy and STI? What is this booklet for? This booklet gives basic information about planning a family if you are living with
More informationReview of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)
Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW) Submission: Elizabeth Glaser Pediatric AIDS Foundation June 2013 Introduction:
More informationACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS
ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with
More informationThe NEW ARV Guidelines FAQs
The NEW ARV Guidelines FAQs Dr Madeleine Muller MBChB (Pret).MRCGP(Lon).Dip Hiv Man IYDSA Clinical Advisor Acknowledgments IYDSA for materials and support NDOH for slides CDC our funder HIV Clinician Society
More informationWESTERN CAPE ART GUIDELINES PRESENTATION 2013
WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More informationPublic Health in the Age of HIV: Reflections and Redirections The 2 nd Annual UWC HIV In Context Research Symposium
Public Health in the Age of HIV: Reflections and Redirections The 2 nd Annual UWC HIV In Context Research Symposium UWC Centre for Research in HIV and AIDS, UWC School of Public Health, VLIR UOS UWC Dynamics
More informationtargets for HIV-positive children
Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of
More informationLIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE
LIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL DEVELOPMENT VENUE: THE RANCH HOTEL DATE:09.03.2010
More information